Treatment of chronic viral hepatitis

被引：12
|
作者：
Wright, M [1 ]
Main, J [1 ]
Thomas, HC [1 ]
机构：
[1] St Marys Hosp, Imperial Coll Sch Med, London, England
来源：
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 2001年 / 12卷 / 04期
关键词：
hepatitis; nucleoside anologues; interferons; targetting; therapy;
D O I：
10.1177/095632020101200401
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Significant advances have been made in the treatment of both hepatitis B and C. Cure for the majority is becoming reality. Combination regimens are now established therapy in hepatitis C and the near future will see the adoption of a similar approach to hepatitis B. Interferon alpha therapy remains important, with the development of more efficacious pegylated forms. In this article we review current therapy and discuss future strategies of the therapy for chronic viral hepatitis.
引用
收藏
页码：201 / 212
页数：12
相关论文
共 50 条
  • [21] Infliximab `safe' in patients with chronic viral hepatitis?
    Reactions Weekly, 2004, 990 (1) : 4 - 4
  • [22] Treatment of parenterally transmittable viral hepatitis
    Durmashkina, Elena
    Zeuzem, Stefan
    Sarrazin, Christoph
    INTERNIST, 2022, 63 (04): : 388 - 396
  • [23] HCC surveillance of patients with chronic viral hepatitis
    Neumann-Haefelin, Christoph
    GASTROENTEROLOGE, 2021, 16 (06): : 450 - 454
  • [24] The Chimpanzee Model of Viral Hepatitis: Advances in Understanding the Immune Response and Treatment of Viral Hepatitis
    Lanford, Robert E.
    Walker, Christopher M.
    Lemon, Stanley M.
    ILAR JOURNAL, 2017, 58 (02) : 172 - 189
  • [25] A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma
    Darvishi, Mohammad
    Nouri, Majid
    Rahimi, Rasoul
    Heidari-Soureshjani, Saeid
    Rafsanjani, Seyed Mahmoud Reza Hashemi
    CURRENT MOLECULAR MEDICINE, 2024,
  • [26] Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C
    Aguilar Reina, J.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (10) : 665 - 667
  • [27] Sustained Viral Response and Hematological Adverse Events During Chronic Hepatitis C Infection Treatment
    El-Shabrawi, Mortada
    Isa, Mona
    HEPATITIS MONTHLY, 2012, 12 (02) : 122 - 123
  • [28] Rapid evolution of chronic viral hepatitis into hepatocellular carcinoma after beta-interferon treatment
    Malaguarnera, M
    Restuccia, S
    Di Fazio, I
    Di Marco, R
    Pistone, G
    Trovato, BA
    PANMINERVA MEDICA, 1999, 41 (01) : 59 - 61
  • [29] Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection
    Cho, J-H.
    Lim, J-H.
    Park, G-Y.
    Kim, J-S.
    Kang, Y-J.
    Kwon, O.
    Choi, J-Y.
    Park, S-H.
    Kim, Y-L.
    Kim, H-K.
    Huh, S.
    Kim, C-D.
    TRANSPLANT INFECTIOUS DISEASE, 2014, 16 (02) : 295 - 303
  • [30] Durability of viral response after off-treatment in HBeAg positive chronic hepatitis B
    Song, Myeong Jun
    Song, Do Seon
    Kim, Hee Yeon
    Yoo, Sun Hong
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    Paik, Yong-Han
    Lee, June Sung
    Lee, Hyun Woong
    Kim, Hyung Joon
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (43) : 6277 - 6283
12345